The chemical class termed LIMCH1 Activators encompasses a diverse array of molecules unified by their common ability to positively modulate the expression or activity of the LIMCH1 protein. These activators operate through a spectrum of molecular mechanisms, each honing in on various regulatory checkpoints that govern the synthesis and stability of LIMCH1. Such mechanisms include the modulation of transcriptional activity, enhancement of mRNA stability, and inhibition of protein degradation pathways. Some members of this class, such as epigenetic modulators, work at the genomic level, altering the chromatin structure or DNA methylation status to promote the transcription of the LIMCH1 gene. By doing so, they facilitate the recruitment of transcriptional machinery, thus enabling the initiation of gene expression.
On the other hand, another subset of LIMCH1 Activators focuses on post-transcriptional and post-translational modifications. By affecting mRNA stability and translation efficiency, these chemicals ensure that the transcribed mRNA is effectively utilized for protein synthesis. Additionally, compounds that inhibit proteasomal degradation pathways fall under this category, as they contribute to the stabilization and prolonged presence of the LIMCH1 protein within cellular compartments. The collective action of LIMCH1 Activators underscores the multifaceted regulatory mechanisms that contribute to the precise control of protein expression, showcasing the intricacies of cellular regulation and the potential avenues for modulating the activity of specific proteins like LIMCH1.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC inhibitor that promotes a more relaxed chromatin structure, potentially leading to increased gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another HDAC inhibitor that could enhance gene transcription by promoting open chromatin structure. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor which can prevent the methylation of DNA, potentially leading to enhanced gene expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Influences mRNA stability which might lead to prolonged protein synthesis. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor which can prevent protein degradation, potentially leading to increased protein levels. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor which might modulate pathways that indirectly influence LIMCH1 expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
DNA methyltransferase and cytidine deaminase inhibitor, potentially promoting gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor that might enhance gene transcription by affecting chromatin structure. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can lead to increased protein levels by preventing their degradation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that may affect cellular pathways, potentially influencing LIMCH1 expression indirectly. | ||||||